Abstract
To estimate the rate of inappropriate diagnosis in patients who visited the ED with thrombotic microangiopathy (TMA) and to assess the factors and outcomes associated with emergency department (ED) misdiagnosis. Retrospective multicenter study of adult patients admitted to the intensive care unit (ICU) for TMA from 2012 to 2021 who had previously attended the ED for a reason related to TMA. Patient characteristics and outcomes were compared in a univariate analysis based on whether a TMA diagnosis was mentioned in the ED or not. Forty patients were included. The diagnosis of TMA was not mentioned in the ED in 16 patients (40%). Patients for whom the diagnosis was mentioned in the ED had more frequently a request for schistocytes research, and therefore had more often objectified schistocytes. They also had more frequently a troponin dosage in the ED (even if the difference was not significant), an ECG performed or interpreted, and were admitted more quickly in the ICU (0 [0–0] vs 2 [0–2] days; P = 0.002). Hemoglobin levels decreased significantly in both groups, and creatinine levels increased significantly in the misdiagnosis group between ED arrival and ICU admission. In patients with a final diagnosis of TTP, the time to platelets durable recovery was shorter for those in whom the diagnosis was mentioned in the ED without reaching statistical significance (7 [5–11] vs 14 [5–21] days; P = 0.3).
Similar content being viewed by others
Data availability
Not applicable.
References
Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600
Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P et al French Reference Center for Thrombotic Microangiopathies (2016) Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol 3:e237–e245
Fodil S, Zafrani L (2022) Severe thrombotic thrombocytopenic purpura (TTP) with organ failure in critically ill patients. J Clin Med 11:1103
Coppo P, Veyradier A (2009) Thrombotic microangiopathies: towards a pathophysiology-based classification. Cardiovasc Hematol Disord Drug Targets 9:36–50
Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P et al (2017) Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre. Am J Hematol 92:381–387
Renaud A, Caristan A, Seguin A, Agard C, Blonz G, Canet E et al (2021) Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura. PLoS ONE 16:e0260196
Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C et al (2010) Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS ONE 5:e10208
Schmidt J, Zafrani L, Lemiale V, Stepanian A, Joly B, Azoulay E et al (2021) The clinical picture of thrombotic microangiopathy in patients older than 60 years of age. Br J Haematol 192:e25–e28
Long B, Bridwell RE, Manchanda S, Gottlieb M (2021) Evaluation and management of thrombotic thrombocytopenic purpura in the emergency department. J Emerg Med 61:674–682
Kessler CS, Khan BA, Lai-Miller K (2012) Thrombotic thrombocytopenic purpura: a hematological emergency. J Emerg Med 43:538–544
Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN (2017) Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv 1:590–600
Scully M, Yarranton H, Liesner R, Cavenagh J, Hunt B, Benjamin S et al (2008) Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 142:819–826
Peyrony O, Gamelon D, Brune R, Chauvin A, Ghazali DA, Yordanov Y et al (2021) Red blood cell transfusion in the emergency department: an observational cross-sectional multicenter study. J Clin Med 10:2475
Demagny J, Roussel C, Le Guyader M, Guiheneuf E, Harrivel V, Boyer T et al (2022) Combining imaging flow cytometry and machine learning for high-throughput schistocyte quantification: a SVM classifier development and external validation cohort. EBioMedicine 83:104209
Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, Lämmle B et al (2013) Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 122:2023–2029
Scully M, Rayment R, Clark A, Westwood JP, Cranfield T, Gooding R et al BSH Committee (2023) A British society for haematology guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies. Br J Haematol https://doi.org/10.1111/bjh.19026
HaemSTAR Collaborators (2022) Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019. J Thromb Haemost 20:1428–1436
Benhamou Y, Boelle PY, Baudin B, Ederhy S, Gras J, Galicier L et al Reference Center for Thrombotic Microangiopathies (2015) Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center. J Thromb Haemost 13:293–302
Van de Louw A, Mariotte E, Darmon M, Cohrs A, Leslie D, Azoulay E (2021) Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era. PLoS ONE 16:e0256024
Sawler D, Parker A, Britto J, Goodyear MD, Sun HL (2020) Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: a 10-year provincial retrospective cohort study. Thromb Res 193:53–59
Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F et al (2015) Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center. Am J Hematol 90:E127–E129
Mariotte E, Blet A, Galicier L, Darmon M, Parquet N, Lengline E et al (2013) Unresponsive thrombotic thrombocytopenic purpura in critically ill adults. Intensive Care Med 39:1272–1281
Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A et al (2020) ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 18:2486–2495
Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A et al (2017) Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol 4:e157–e164
Acknowledgements
Authors would like to thank OP’s post-doctoral fellow financial support: la Ligue Nationale contre le Cancer (convention number: AAPMRC 2022/OP) and la Direction de l'Assistance Publique—Hôpitaux de Paris (APHP).
Funding
None.
Author information
Authors and Affiliations
Contributions
Conception and design: IdB, LZ, OP. Provision of study materials of patients: SE, CK, ALFP, CG, AC, SB, ED, LP, RC, MK, EM, LZ. Collection and assembly of data: IdB, SE, LZ, OP. Data analysis and interpretation: IdB, OP. Manuscript writing: IdB, OP. Final approval of manuscript: IdB, SE, CK, ALFP, CG, AC, SB, ED, LP, RC, MK, EM, LZ, OP.
Corresponding author
Ethics declarations
Conflict of interest
OP has received honoraria for talks on behalf of BMS and Qiagen, and expertise for Sanofi. EM has received lecture fees from Sanofi and Takeda. LZ reports receiving fees for lectures for MSD and Sanofi and her institution received a research grant from Jazz Pharmaceuticals.
Consent to participate
Not applicable.
Ethical approval
The collection and use of data was approved by the institutional review board (CIC Clermont-Ferrand — IRB no. 5891; Ref: 2007–16).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
de Boisriou, I., Ellouze, S., Kassasseya, C. et al. Misdiagnosis of thrombotic microangiopathy in the emergency department: a multicenter retrospective study. Intern Emerg Med 19, 115–124 (2024). https://doi.org/10.1007/s11739-023-03457-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-023-03457-8